Article Details
Retrieved on: 2018-08-11 22:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Sofinnova Ventures</b> Inc purchased a new stake in shares of Aclaris Therapeutics during the first quarter worth about $26,972,000. Citadel Advisors ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here